NCT02350725View on ClinicalTrials.gov

Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Heart Failure
Interventions
DRUG

Furosemide injection solution for subcutaneous administration (80 mg)

DRUG

Oral Furosemide tablets (80 mg)

Trial Locations (1)

Unknown

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

scPharmaceuticals, Inc.

INDUSTRY

NCT02350725 - Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration | Biotech Hunter | Biotech Hunter